| - GRCh37:
- Chr11:60948809-61284302
- GRCh38:
- Chr11:61181337-61516830
| CPSF7, CYB561A3, DDB1, LOC121392920, LOC126861223, LOC126861224, LRRC10B, MIR4488, PGA3, PGA4, PGA5, PPP1R32, SDHAF2, SYT7, TKFC, TMEM138, TMEM216, VWCE | | See cases | Uncertain significance (Sep 21, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr11:61177001-61588631
- GRCh38:
- Chr11:61409529-61821159
| CPSF7, DAGLA, FADS1, FADS2, FEN1, LOC101927495, LOC111818968, LOC121392920, LOC121392921, LOC124489747, LOC126861225, LRRC10B, MIR1908, MIR4488, MIR611, MYRF, MYRF-AS1, PPP1R32, SDHAF2, SYT7, TMEM258 | | See cases | Likely benign (Nov 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr11:61197461
- GRCh38:
- Chr11:61429989
| SDHAF2 | | not provided | Benign (Jun 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197569
- GRCh38:
- Chr11:61430097
| SDHAF2 | | not specified | Likely benign (Nov 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197590
- GRCh38:
- Chr11:61430118
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197608
- GRCh38:
- Chr11:61430136
| SDHAF2 | | not specified | Likely benign (Mar 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197614
- GRCh38:
- Chr11:61430142
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197614
- GRCh38:
- Chr11:61430142
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Apr 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197618
- GRCh38:
- Chr11:61430146
| SDHAF2 | | Paragangliomas 2, Hereditary cancer-predisposing syndrome, not provided
| Conflicting interpretations of pathogenicity (Mar 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61197620
- GRCh38:
- Chr11:61430148
| SDHAF2 | M1T | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197621
- GRCh38:
- Chr11:61430149
| SDHAF2 | M1I | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197622
- GRCh38:
- Chr11:61430150
| SDHAF2 | A2S | Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197623
- GRCh38:
- Chr11:61430151
| SDHAF2 | A2V | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197624
- GRCh38:
- Chr11:61430152
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Likely benign (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197624
- GRCh38:
- Chr11:61430152
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome, not provided
| Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197625
- GRCh38:
- Chr11:61430153
| SDHAF2 | V3M | Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197625
- GRCh38:
- Chr11:61430153
| SDHAF2 | V3L | Hereditary cancer-predisposing syndrome, not provided, Hereditary pheochromocytoma-paraganglioma
| Conflicting interpretations of pathogenicity (Mar 7, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61197626
- GRCh38:
- Chr11:61430154
| SDHAF2 | V3A | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197627
- GRCh38:
- Chr11:61430155
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197627
- GRCh38:
- Chr11:61430155
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197627
- GRCh38:
- Chr11:61430155
| SDHAF2 | | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Likely benign (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197628
- GRCh38:
- Chr11:61430156
| SDHAF2 | S4A | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197629
- GRCh38:
- Chr11:61430157
| SDHAF2 | S4F | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197629
- GRCh38:
- Chr11:61430157
| SDHAF2 | S4C | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197630
- GRCh38:
- Chr11:61430158
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Likely benign (May 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197630
- GRCh38:
- Chr11:61430158
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197631
- GRCh38:
- Chr11:61430159
| SDHAF2 | T5A | Hereditary cancer-predisposing syndrome, not provided, Hereditary pheochromocytoma-paraganglioma
| Uncertain significance (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197632
- GRCh38:
- Chr11:61430160
| SDHAF2 | T5I | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197633
- GRCh38:
- Chr11:61430161
| SDHAF2 | | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Benign/Likely benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197635
- GRCh38:
- Chr11:61430163
| SDHAF2 | V6A | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197636
- GRCh38:
- Chr11:61430164
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197636
- GRCh38:
- Chr11:61430164
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Likely benign (Sep 27, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197637
- GRCh38:
- Chr11:61430165
| SDHAF2 | F7L | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197637
- GRCh38:
- Chr11:61430165
| SDHAF2 | F7V | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197639
- GRCh38:
- Chr11:61430167
| SDHAF2 | F7L | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197639
- GRCh38:
- Chr11:61430167
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197640
- GRCh38:
- Chr11:61430168
| SDHAF2 | S8P | Hereditary cancer-predisposing syndrome | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197640
- GRCh38:
- Chr11:61430168
| SDHAF2 | S8T | Hereditary cancer-predisposing syndrome | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197641
- GRCh38:
- Chr11:61430169
| SDHAF2 | S8W | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197641
- GRCh38:
- Chr11:61430169
| SDHAF2 | S8L | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197641
- GRCh38:
- Chr11:61430169
| SDHAF2 | S8* | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61197642
- GRCh38:
- Chr11:61430170
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Likely benign (Jan 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197642
- GRCh38:
- Chr11:61430170
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197642
- GRCh38:
- Chr11:61430170
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Likely benign (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197643
- GRCh38:
- Chr11:61430171
| SDHAF2 | T9A | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Conflicting interpretations of pathogenicity (Jun 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61197644
- GRCh38:
- Chr11:61430172
| SDHAF2 | T9I | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197645
- GRCh38:
- Chr11:61430173
| SDHAF2 | S10fs | Hereditary pheochromocytoma-paraganglioma | Pathogenic (Aug 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197646
- GRCh38:
- Chr11:61430174
| SDHAF2 | S10T | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197647
- GRCh38:
- Chr11:61430175
| SDHAF2 | S10W | Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197647
- GRCh38:
- Chr11:61430175
| SDHAF2 | S10fs | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61197647
- GRCh38:
- Chr11:61430175
| SDHAF2 | S10L | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197648
- GRCh38:
- Chr11:61430176
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Dec 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197650
- GRCh38:
- Chr11:61430178
| SDHAF2 | S11* | Hereditary pheochromocytoma-paraganglioma | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197650
- GRCh38:
- Chr11:61430178
| SDHAF2 | S11W | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197650
- GRCh38:
- Chr11:61430178
| SDHAF2 | S11L | not provided, Paragangliomas 2, Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Likely benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197651
- GRCh38:
- Chr11:61430179
| SDHAF2 | | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Likely benign (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197651
- GRCh38:
- Chr11:61430179
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197651
- GRCh38:
- Chr11:61430179
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197652
- GRCh38:
- Chr11:61430180
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Nov 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197653
- GRCh38:
- Chr11:61430181
| SDHAF2 | L12Q | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197653
- GRCh38:
- Chr11:61430181
| SDHAF2 | L12P | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Nov 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197654
- GRCh38:
- Chr11:61430182
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197655
- GRCh38:
- Chr11:61430183
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely pathogenic (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197655
- GRCh38:
- Chr11:61430183
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197659
- GRCh38:
- Chr11:61430187
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Jun 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197660
- GRCh38:
- Chr11:61430188
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197660-61197663
- GRCh38:
- Chr11:61430188-61430191
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197661-61197663
- GRCh38:
- Chr11:61430189-61430191
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Jul 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197663
- GRCh38:
- Chr11:61430191
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197664
- GRCh38:
- Chr11:61430192
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Paragangliomas 2, not specified
| Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197665
- GRCh38:
- Chr11:61430193
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Oct 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197666
- GRCh38:
- Chr11:61430194
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197666
- GRCh38:
- Chr11:61430194
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197668
- GRCh38:
- Chr11:61430196
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197668
- GRCh38:
- Chr11:61430196
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197670
- GRCh38:
- Chr11:61430198
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197671
- GRCh38:
- Chr11:61430199
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, not specified | Benign/Likely benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61197673
- GRCh38:
- Chr11:61430201
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61197938
- GRCh38:
- Chr11:61430466
| SDHAF2 | | not provided | Likely benign (Jun 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61204921
- GRCh38:
- Chr11:61437449
| SDHAF2 | | not provided | Likely benign (Jun 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205077
- GRCh38:
- Chr11:61437605
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205079
- GRCh38:
- Chr11:61437607
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205087-61213553
- GRCh38:
- Chr11:61437615-61446081
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Oct 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205089
- GRCh38:
- Chr11:61437617
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205090
- GRCh38:
- Chr11:61437618
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Jul 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205091
- GRCh38:
- Chr11:61437619
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Likely benign (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205092
- GRCh38:
- Chr11:61437620
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205095
- GRCh38:
- Chr11:61437623
| SDHAF2 | | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Likely pathogenic (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61205096
- GRCh38:
- Chr11:61437624
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, not provided, Hereditary cancer-predisposing syndrome, Paragangliomas 2 | Pathogenic/Likely pathogenic (Dec 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61205097
- GRCh38:
- Chr11:61437625
| SDHAF2 | M13V | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205097
- GRCh38:
- Chr11:61437625
| SDHAF2 | M13L | Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61205098-61205101
- GRCh38:
- Chr11:61437626-61437629
| SDHAF2 | A15fs | Paragangliomas 2 | Likely pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205100
- GRCh38:
- Chr11:61437628
| SDHAF2 | L14F | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205103
- GRCh38:
- Chr11:61437631
| SDHAF2 | A15P | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205103
- GRCh38:
- Chr11:61437631
| SDHAF2 | A15S | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205105
- GRCh38:
- Chr11:61437633
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Likely benign (Nov 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205106
- GRCh38:
- Chr11:61437634
| SDHAF2 | L16V | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Jul 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205106
- GRCh38:
- Chr11:61437634
| SDHAF2 | | Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome | Likely benign (Aug 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61205108
- GRCh38:
- Chr11:61437636
| SDHAF2 | | Hereditary cancer-predisposing syndrome | Likely benign (Mar 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61205109
- GRCh38:
- Chr11:61437637
| SDHAF2 | S17P | Hereditary cancer-predisposing syndrome | Uncertain significance (Jul 22, 2020) | criteria provided, single submitter |